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The purpose of this study was to compare the stool antigen (SAT) and immunoglobulin G (IgG)
serology tests for in dyspeptic patients in Nigeria, and determine their usefulness.
Forty six patients with dyspepsia and age and sex-matched healthy controls had their blood and stool
collected and screened for H. pylori infection using the enzyme linked immunosorbent assay (ELISA) IgG
serology and SAT respectively.
Prevalence of 67.4% and 78.3%, among dyspeptics and controls respectively ((p=0.48) with the
SAT while the corresponding values for IgG serology were 67.4% and 91.3%, p=0.005).
Patients aged 50 years(8) were more positive to SAT (80%), compared with controls(13) which
recorded more positivity in the age range 30-39 years (92.9%). The male gender had more positive SAT in
patients (n=15, 75%) but the SAT was more positive among the female controls 22(84.6%). Controls in the age
range <30 years were more positive to IgG while the patients were more positive at = 30 yrs 10(100%).
It is concluded that SAT and IgG serology for H. pylori are both useful in diagnosis of the
infection, and are fairly comparable in their ability to detect infection, even in area of high endemicity.
Dyspepsia, stool antigen test, Helicobacter pylori, serology.
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INTRODUCTION
Dyspepsia is a common presenting complaint
encountered in clinical practice affecting about 40%
of the adult population It presents as chronic or
recurrent pain or discomfort in the upper abdomen
often in association with meals/hunger, belching,
bloating, nausea, vomiting, early satiety and
heartburn.
Knowledge about )
has gained prominence in the understanding and
management of dyspepsia in recent times, the
organism having been implicated in the
pathogenesis of many of the gastroduodenal
diseases presenting with dyspepsia.
The prevalence of in developed countries is
reported to be less than 60% in the normal adult
population but the figure is far higher in developing
countries , with a prevalence exceeding 90% even
in normal individuals . In South West Nigeria,
prevalences as high as 88-94.5% were obtained in
some studies using serological methods .
Invasive tests for isolation of employ
gastroduodenal biopsies for culture, urease test,











(PCR). The non-invasive tests, however, do not
require tissue biopsies, and include urea breath test
(UBT), immunoglobulin G or M (IgG, IgM) serology,
and lately, saliva antibody test and detection of
antigen in stool samples .
Serological screening, though widely used, is of
limited value in the detection of current infection,
especially in hyper-endemic areas like Nigeria since
it may represent a current or a previous exposure to
the organism. UBT detects current infection but is
cumbersome, expensive and requires the use of
radioactive material and highly technical equipment
and manpower.
Stool antigen test (SAT) is based on detection of
antigen in the stool and therefore detects
current infection . Moreover, samples for SAT could
easily be obtained by patients in the privacy of their
home, obviating the need for venepuncture with
attendant potential risk of infection to the patient and
phlebotomist and analysis could be carried out in
most routine laboratories within hours. In view of the
high prevalence of infection, the cost,
inconvenience and risks associated with
gastroduodenal endoscopy and the reluctance of
many patients to undergo invasive procedures, SAT
might provide a cost-effective, rapid and reliable
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RESULTS
Forty-six subjects (20 males, 26 females) and 46
controls (20 males, 26 females) aged 18 years and
above participated in the study. The mean age of
subjects was 40.87±13.3 years while that of controls
was 40.83±13.2 years (p=0.9).
The prevalence of using both IgG serology
and SAT were statistically significantly greater in
controls compared with the patients. For IgG
serology, 42(91.3%) controls were positive
compared with 31(67.4%) among dyspeptic patients,
(p=0.05). There were also more positive SAT in
controls compared with the dyspeptic patients,
36(78.3%) vs. 31(67.4%) Table 1 and Fig. 1. This,
however, did not reach statistical significance,
(p=0.48). Equivocal result was obtained in one
subject each in both patients and controls for the SAT.
Tables 1 and 2.
Subjects aged 50 years were more positive to SAT
and so were controls in the age range of 30-39 years
(n=13, 92.9%), through to age 49 (10%), (Table 3).
The SAT had a slightly higher proportion of positives
in the male patients 15(75%) compared with the
controls 14 (70%). The reverse was however the case
for IgG serology in which case, the controls
18 (90%) were in the higher proportion. There were
more positive SAT among the female controls
22(84.6%) compared with female subjects,
16(61.5%). The differences observed in age and sex
were however not statistically significant. Table 3.
Controls in the age range <30 years had more positive
IgG 10(100%). Males were more positive to
IgG among the subjects, 16(80.0%), while
the females were more positive among the controls
24(92.3%). Stratified analyses, however, did not
reveal age and sex as confounding variables in the









Table 1: Serology and Stool Antigen Test in
Subjects and Controls.
eradication assessment in patients with dyspepsia.
The objective of this study was to determine the
prevalence of H. pylori infection among dyspeptic
patients using the SAT and compare with the IgG
serology as well as determine the usefulness of the
SAT in an endemic region of the world.
Forty-six consecutive patients with clinical features
of dyspepsia and 46 age and sex-matched apparently
healthy controls were recruited from the general and
medical outpatient departments of the University
College Hospital (UCH), Ibadan, over a twelve-
month period. Control subjects were individual
volunteers with no history of gastrointestinal disease
outside the hospital setting and some administrative
staff of the University of Ibadan and the UCH,
Ibadan.
Inclusion criteria were persistence of dyspeptic
symptoms for a minimum of three months, while
individuals who had taken anti- eradication
treatment, proton pump inhibitors or other anti-
secretory drugs or antibiotics within the four weeks
preceding the test were excluded. Subjects who had
taken bismuth compounds in the four weeks
preceding test or with clinical features of gastro-
oesophageal reflux disease (GORD), were also
excluded. Clinical examination was carried out on
all participants and findings were carefully noted,
using a data collection sheet.Five milliliters of whole
venous blood was obtained from each subject and
control. Sera were separated after clot retraction and
frozen at -20 C until analysis.
Similarly, fresh pea-sized stool sample was collected
into a clean universal bottle with a wooden spatula
earlier given to each participant (subject and control)
and frozen at-20 C .
The stool samples were analysed for
antigen using Premier Platinum HpSA , enzyme
immunoassay kit, while the sera were analysed for
IgG antibody using Premier
enzyme immunoassay kit (Meridian Bioscience, Inc.
Cincinnati, Ohio). Positive results are samples with
spectrophotometric optical density (OD) of =0.160
at 450nm wavelength, while negative results are OD
< 0.140 at same wavelength. Equivocal results are
results with OD =0.140 and < 0.160.
The data collected were analysed using SPSS
version 10.0 (SPSS Inc. Chicago Illinois). Means
were expressed as mean ±SD. Categorical variables
were compared with Pearson Chi-square, while
means were compared with 't' test. The equality of
proportions positive between patients and controls
was investigated using the two-sample test of




















Positive 31(67.4%) 42(91.3%) 73(79.3%)
Negative 15(32.6%) 4(8.7%) 19(20.7%)
Stool antigen test for H. pylori(SAT) 1.46 0.48
Positive 31(67.4%) 36(78.3%) 67(72.8%)
Negative 14(30.4%) 9(19.6%) 23(25%)
Equivocal 1(2.2%) 1(2.2%) 2(2.2%)
Table 4:
Mantel-Haeszel X : Age groups= 6.35, p-value
= 0 . 0 1
Sex =6.59, p-value =0.01.
This study showed a slight female preponderance
(56.5% vs. 43.5% males), and a lower mean age (40.8
years) among dyspeptic patients in contrast to the
pattern observed by Jones in the British
population. In the British study, they observed more
complaints of dyspepsia in the older age group and
suggested that the older subjects were probably more
concerned about their health or were afraid of more
serious underlying diseases. They further concluded
that this may be of advantage, in that severe diseases
could be detected early and management instituted
promptly. Regrettably, there was no study on stool
antigen test from developing countries of the world to
compare our study with.
The slight preponderance of females in our study
could reflect a greater consciousness in the issue of
their health, or their ready presentation in the hospital
could be due to emotional/psychosomatic disorders,
which tend to be commoner among the female
gender. In contrast to this study, Ihezue in the
North-Central part of Nigeria, found that most of the
dyspeptics (60%) were males and symptoms were
commoner in those below the age of 40 years.
A67.4% prevalence of was obtained among
the dyspeptic population in this study using both
serology and stool antigen test. Most of the studies
assessing stool antigen test in the diagnosis of
infection were directed at determining the
sensitivity and specificity of the test. Hence, actual
prevalence has not been a subject of serious study and
scrutiny in studied populations. Rather, positives and
negatives were interpreted with respect to a pre-
determined gold standard. However, a study of SAT
carried out in Turkey on 445 subjects aged 2-78 years
Demographic Characteristics and



















































































































































Comparison of Stool Antigen Test and
Serology in Subjects and Controls.
Prevalence of using
IgG(Hp IgG) and StoolAntigen Test (HpSA)
Demographic Characteristics and Stool
Antigen among Subjects and Controls.
H. pylori H. pylori
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Subjects SAT Positive 24(77.4) 7(46.7) 31(67.4) 0.067
Negative 7(22.6) 7(46.7) 14(30.4) χ 2=5.41
Equivocal - 1(6.7) 1(2.2)
Controls SAT Positive 35(83.3) 1(25) 36(78.3)


















of 268 (85%) subjects were seropositive for ,
yet only 58 (25.4%) of them had symptoms of
dyspepsia. As observed in such earlier studies
conducted in this part of the world, in addition to the
high prevalence of among controls, the
cause of dyspepsia here may be of multifactorial
origin . This may be the likely reason why
has attracted the eponym of an
African enigma.
A closer look at the sero- and faeco-prevalences in
dyspeptics, reveals a high degree of concordance. On
the strength of this, it can be deduced that the stool
antigen test and IgG serology can give a fair
representation of the true prevalence of in
dyspeptics in Nigeria. In the control group, however,
the significant disparity in the sero- and faeco-
prevalences may not allow for interchangeability of
the two tests. Based on the principle behind the stool
antigen test, it can be concluded that the actual
prevalence of in controls is 78.3%.
There is no significant difference in the
faecoprevalences in the various age groups among
the dyspeptics unlike in the Turkish study in which a
steady increase with age was noticed. In addition,
there is neither a significant age preponderance
among the controls nor any significant sex
predilection among both dyspeptics and controls in
this study. It does not appear that a particular gender
increases the risk of
It is concluded that the SAT, apart from being non-
invasive and easy to carry out, is useful and
comparable to the IgG serology in determining the
prevalence of in dyspeptic patients in
Nigeria. A larger community-based study with
information on strains of and local cut-off
values is suggested, to further evaluate the usefulness
of these tests and compare with histology, presently
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showed a prevalence of 36.6% . Age stratification
showed that the prevalence of in those aged
16-78 years in that same study was 42.4%. The
population in our study is smaller than in the Turkish
study, and probably, a larger population study might
affect the faecoprevalence obtained. It is also
important to note that even though a similar kit was
used in the Turkish study, a higher cut-off value was
used in determining the positive cases in that study
and this might account for the relatively lower
prevalence in their study.
There is a dearth of case control studies in the
assessment of the faecoprevalence of as
researchers focus on the symptomatic population.
This is not surprising since various studies carried
out both in adult and juvenile populations depicted
good sensitivity and specificity and generally, the
prevalence of (evaluated by various
diagnostic methods) has often been reported as being
higher in the dyspeptic group than in the
asymptomatic controls The faecoprevalence among
dyspeptics in this study is comparable to the values
obtained through other diagnostic tests. Using CLO-
urease test and histology, Ndububa reported a
prevalence of 73% among dyspeptics at Ile-Ife,
Nigeria..
The fact that there has not been much experience
with stool antigen test in contrast to serology in this
environment prompted this case control study. It is
surprising to note that the faecoprevalence of
is higher among controls compared with
dyspeptic patients in this environment, though not
statistically significant (78.3% vs 67.4%, p=0.48).
This result was corroborated by a similarly higher
seroprevalence among the same healthy control
population, and this is statistically significant (91.3%
vs 67.4%). The sero- and faeco-prevalences in the
dyspeptic subjects are similar whereas the
seroprevalence in the control is higher than the
faecoprevalence. This is not unexpected when one
considers that an individual may possess antibody to
subsequent to previous exposure, even
though he may not be currently infected with the
organism.
A seroprevalence of 91.3% among controls is
comparable to the 92.7% obtained by Otegbayo
in the same part of the country. The relatively
lower seroprevalence among dyspeptics in our study
may be due to antibiotic abuse, a common practice in
this part of the world. Also worth considering is the
fact that patients with functional dyspepsia usually
constitute the larger percentage of dyspeptic cases
and such patients are known to have more
emotional/psychosomatic complaints and
consequently more frequent hospital visits.
In a random serological survey conducted by
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